These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597 [TBL] [Abstract][Full Text] [Related]
3. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations. Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192 [TBL] [Abstract][Full Text] [Related]
4. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma. Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986 [TBL] [Abstract][Full Text] [Related]
5. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678 [TBL] [Abstract][Full Text] [Related]
6. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy. Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553 [TBL] [Abstract][Full Text] [Related]
7. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383 [TBL] [Abstract][Full Text] [Related]
9. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma. Gai QJ; Fu Z; He J; Mao M; Yao XX; Qin Y; Lan X; Zhang L; Miao JY; Wang YX; Zhu J; Yang FC; Lu HM; Yan ZX; Chen FL; Shi Y; Ping YF; Cui YH; Zhang X; Liu X; Yao XH; Lv SQ; Bian XW; Wang Y Signal Transduct Target Ther; 2022 Feb; 7(1):33. PubMed ID: 35105853 [TBL] [Abstract][Full Text] [Related]
10. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Riemenschneider MJ; Mueller W; Betensky RA; Mohapatra G; Louis DN Am J Pathol; 2005 Nov; 167(5):1379-87. PubMed ID: 16251422 [TBL] [Abstract][Full Text] [Related]
11. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. Eller JL; Longo SL; Hicklin DJ; Canute GW Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411 [TBL] [Abstract][Full Text] [Related]
12. EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma. Yeo AT; Jun HJ; Appleman VA; Zhang P; Varma H; Sarkaria JN; Charest A Oncogene; 2021 Apr; 40(15):2682-2696. PubMed ID: 33707748 [TBL] [Abstract][Full Text] [Related]